当前位置:首页 - 行情中心 - 千红制药(002550) - 财务分析 - 现金流量表

千红制药

(002550)

  

流通市值:97.42亿  总市值:132.46亿
流通股本:9.41亿   总股本:12.80亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金800,568,355.51390,908,222.871,676,927,387.21,250,288,363.73
  收到的税费返还166,248.01149,770.221,117,030.7113,961,684.2
  收到其他与经营活动有关的现金19,008,921.3810,643,876.2232,864,395.4638,982,983.96
  经营活动现金流入小计819,743,524.9401,701,869.311,710,908,813.371,303,233,031.89
  购买商品、接受劳务支付的现金339,538,295.46161,923,278.1495,609,925.68355,040,222.11
  支付给职工以及为职工支付的现金123,639,900.8669,782,403.18194,442,795.01159,473,556.56
  支付的各项税费67,622,749.5330,760,392.77151,771,394.76119,773,541.07
  支付其他与经营活动有关的现金143,106,397.6167,724,107.01354,375,623.46218,195,686.41
  经营活动现金流出小计673,907,343.46330,190,181.061,196,199,738.91852,483,006.15
  经营活动产生的现金流量净额145,836,181.4471,511,688.25514,709,074.46450,750,025.74
二、投资活动产生的现金流量:
  收回投资收到的现金--63,390,904.26-
  取得投资收益收到的现金4,737,594.541,647,703.336,056,538.382,178,905.09
  处置固定资产、无形资产和其他长期资产收回的现金净额0-13,500,00013,500,000
  收到的其他与投资活动有关的现金916,001,823.25490,167,089.8202,698,258.36229,502,741.7
  投资活动现金流入小计920,739,417.79491,814,793.13285,645,701245,181,646.79
  购建固定资产、无形资产和其他长期资产支付的现金60,708,517.9420,825,106.3590,638,308.8834,952,467.72
  投资支付的现金--143,656,422.74-
  支付其他与投资活动有关的现金679,853,000343,003,000374,580,000269,006,756.08
  投资活动现金流出小计740,561,517.94363,828,106.35608,874,731.62303,959,223.8
  投资活动产生的现金流量净额180,177,899.85127,986,686.78-323,229,030.62-58,777,577.01
三、筹资活动产生的现金流量:
  吸收投资收到的现金--3,000,0003,000,000
  其中:子公司吸收少数股东投资收到的现金--3,000,000-
  取得借款收到的现金--4,690,000-
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--7,690,0003,000,000
  偿还债务支付的现金600,000-40,103,50035,484,000
  分配股利、利润或偿付利息支付的现金150,837,240.79676,735.97151,521,781.68151,845,712.08
  支付其他与筹资活动有关的现金0-140,770,172.94140,770,172.94
  筹资活动现金流出小计151,437,240.79676,735.97332,395,454.62328,099,885.02
  筹资活动产生的现金流量净额-151,437,240.79-676,735.97-324,705,454.62-325,099,885.02
四、汇率变动对现金及现金等价物的影响-1,137,744.46-217,949.66-1,847,664.71-4,431,206.68
五、现金及现金等价物净增加额173,439,096.04198,603,689.4-135,073,075.4962,441,357.03
  加:期初现金及现金等价物余额439,945,400.01439,945,400.01575,018,475.5575,018,475.5
  期末现金及现金等价物余额613,384,496.05638,549,089.41439,945,400.01637,459,832.53
补充资料:
  净利润249,582,175.18-333,182,546.82-
  资产减值准备-51,995,351.1--75,826,178.17-
  固定资产和投资性房地产折旧28,953,674.22-61,597,131.77-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧28,953,674.22-61,597,131.77-
  无形资产摊销1,860,339.43-3,891,548.78-
  长期待摊费用摊销1,927,044.3-4,387,266.47-
  固定资产报废损失29,737.73-38,446.18-
  公允价值变动损失-2,768,482.85--2,359,456.78-
  财务费用2,211,042.83-3,234,127.17-
  投资损失-5,025,058.69--11,529,730.94-
  递延所得税7,590,764.04-14,776,384.38-
  其中:递延所得税资产减少8,143,009.62-15,270,752.13-
    递延所得税负债增加-552,245.58--494,367.75-
  存货的减少68,884,135.02-172,105,649.62-
  经营性应收项目的减少-94,972,373.31--12,255,493.78-
  经营性应付项目的增加-60,441,465.36-24,090,244.95-
  其他---623,412.01-
  现金的期末余额613,384,496.05-439,945,400.01-
  减:现金的期初余额439,945,400.01-575,018,475.5-
  现金及现金等价物的净增加额173,439,096.04--135,073,075.49-
公告日期2025-08-232025-04-192025-04-192024-10-18
审计意见(境内)标准无保留意见
TOP↑